Chronic cough: Investigations, management, current and future treatments
暂无分享,去创建一个
L. Boulet | S. Field | J. Bourbeau | P. Lin | I. Satia | E. Kum | H. Kim | M. Wahab | A. Kaplan | P. Hernández
[1] J. Smith,et al. An open-label study of the tolerability and potential efficacy of memantine for treating refractory chronic cough , 2021, ERJ Open Research.
[2] S. Birring,et al. Eliapixant (BAY 1817080), a P2X3 receptor antagonist, in refractory chronic cough: a randomised, placebo-controlled, crossover phase 2a study , 2021, The European respiratory journal.
[3] A. Chang,et al. Global physiology and pathophysiology of cough: Part 2. Demographic and clinical considerations: CHEST Expert Panel report. , 2021, Chest.
[4] J. Smith,et al. Performance of a digital signal processing algorithm for the accurate quantification of cough frequency , 2021, European Respiratory Journal.
[5] S. Birring,et al. Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses , 2021, The Lancet Respiratory Medicine.
[6] S. Birring,et al. Characterization of Patients With Refractory or Unexplained Chronic Cough Participating in a Phase 2 Clinical Trial of the P2X3-Receptor Antagonist Gefapixant , 2021, Lung.
[7] Corrections: Investigations and management of chronic cough: a 2020 update from the European Respiratory Society Chronic Cough Task Force. , 2021, Polish archives of internal medicine.
[8] J. Smith,et al. A Randomized Controlled Trial to Assess the Effect of Lidocaine Administered via Throat Spray and Nebulization in Patients with Refractory Chronic Cough. , 2020, The journal of allergy and clinical immunology. In practice.
[9] V. Varney,et al. Longstanding tracheobronchomalacia: A forgotten cause of severe cough and its response to roflumilast , 2020, Respiratory Medicine Case Reports.
[10] C. Stoll,et al. Curbing the Cough: Multimodal Treatments for Neurogenic Cough: A Systematic Review and Meta‐Analysis , 2020, The Laryngoscope.
[11] J. Smith,et al. Aprepitant For Cough in Lung Cancer: A Randomised Placebo-Controlled Trial and Mechanistic Insights. , 2020, American journal of respiratory and critical care medicine.
[12] I. Pavord,et al. Late Breaking Abstract - Two Phase 3 Randomized Clinical Trials of Gefapixant, a P2X3 Receptor Antagonist, in Refractory or Unexplained Chronic Cough (COUGH-1 and COUGH-2) , 2020 .
[13] J. Smith,et al. The Efficacy of Bradanicline in Refractory Chronic Cough , 2020 .
[14] S. Birring,et al. Global physiology and pathophysiology of cough: Part 1. Cough phenomenology: CHEST Guideline and Expert Panel report. , 2020, Chest.
[15] J. Smith,et al. The effect of pain conditioning on experimentally evoked cough: evidence of impaired endogenous inhibitory control mechanisms in refractory chronic cough , 2020, European Respiratory Journal.
[16] P. O'Byrne,et al. Investigating the Repeatability of Cough Endpoints from the Mannitol Inhalation Cough Challenge (MICC) , 2020 .
[17] S. Birring,et al. Safety and Efficacy of BAY 1817080, a P2X3 Receptor Antagonist, in Patients with Refractory Chronic Cough (RCC) , 2020 .
[18] P. O'Byrne,et al. Mannitol Evoked Cough Responses; Evidence of Neuronal Dysfunction in Allergic Asthmatics and Females , 2020 .
[19] P. O'Byrne,et al. Tracheobronchomegaly, cough and recurrent chest infection: Mounier-Kuhn syndrome , 2020, ERJ Open Research.
[20] P. Dicpinigaitis,et al. Quantitative measurement properties and score interpretation of the Cough Severity Diary in patients with chronic cough , 2020, Therapeutic advances in respiratory disease.
[21] H. Koskela,et al. Cough-provocation tests with hypertonic aerosols , 2020, ERJ Open Research.
[22] M. Farrell,et al. A role for neurokinin 1 receptor expressing neurons in the paratrigeminal nucleus in bradykinin‐evoked cough in guinea‐pigs , 2020, The Journal of physiology.
[23] A. Morice,et al. Drug-Induced Cough. , 2020, Physiological research.
[24] Feng Wu,et al. A new simple score of chronic cough: cough evaluation test , 2020, BMC Pulmonary Medicine.
[25] M. Farrell,et al. Peripheral and central mechanisms of cough hypersensitivity , 2020, Journal of thoracic disease.
[26] S. Birring,et al. Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial. , 2020, The Lancet. Respiratory medicine.
[27] R. Irwin,et al. Chronic Cough Due to Stable Chronic Bronchitis: CHEST Expert Panel Report. , 2020, Chest.
[28] P. Dicpinigaitis,et al. Falsely Accused? Insufficient Evidence to Conclude that Sitagliptin is a Cause of Chronic Cough , 2020, Lung.
[29] L. Boulet,et al. Managing Chronic Cough due to Asthma and NAEB in Adults and Adolescents: CHEST Guideline and Expert Panel Report. , 2020, Chest.
[30] J. Smith,et al. Gefapixant in two randomised dose-escalation studies in chronic cough , 2020, European Respiratory Journal.
[31] S. Birring,et al. ERS guidelines on the diagnosis and treatment of chronic cough in adults and children , 2019, European Respiratory Journal.
[32] S. Birring,et al. S27 A placebo-controlled, double-blind, randomised, crossover study to assess the efficacy, safety and tolerability of TRPV4 inhibitor GSK2798745 in participants with chronic cough , 2019, What’s new? Clinical trials in lung disease.
[33] J. Smith,et al. Late Breaking Abstract - The neurokinin-1 receptor antagonist orvepitant improves chronic cough symptoms: results from a Phase 2b trial , 2019, Clinical Problems.
[34] A. Niimi,et al. Late Breaking Abstract - Phase 2a randomised, double-blind, placebo-controlled, crossover study of a novel P2X3 receptor antagonist S-600918 in patients with refractory chronic cough , 2019, Airway pharmacology and treatment.
[35] S. Birring,et al. The Effect of Aclidinium on Symptoms Including Cough in Chronic Obstructive Pulmonary Disease: A Phase 4, Double-Blind, Placebo-controlled, Parallel-Group Study , 2019, American journal of respiratory and critical care medicine.
[36] Vaninder K. Dhillon. Superior laryngeal nerve block for neurogenic cough: A case series , 2019, Laryngoscope investigative otolaryngology.
[37] N. Chauret,et al. BLU-5937: A selective P2X3 antagonist with potent anti-tussive effect and no taste alteration. , 2019, Pulmonary pharmacology & therapeutics.
[38] D. Kim,et al. Development and validation of the COugh Assessment Test (COAT) , 2019, Respirology.
[39] S. Birring,et al. Impaired cough suppression in chronic refractory cough , 2019, European Respiratory Journal.
[40] Speech and language therapy for management of chronic cough. , 2018, The Cochrane database of systematic reviews.
[41] J. Smith,et al. The Neurokinin-1 Receptor Antagonist Orvepitant is a Novel Antitussive Therapy for Chronic Refractory Cough: Results from a Phase 2 Pilot Study (VOLCANO-1). , 2019, Chest.
[42] G. M. Allan,et al. What are the most common conditions in primary care? Systematic review. , 2018, Canadian family physician Medecin de famille canadien.
[43] C. Strange,et al. Inhaled corticosteroids for chronic obstructive pulmonary disease: what is their role in therapy? , 2018, International journal of chronic obstructive pulmonary disease.
[44] Richard J Martin,et al. New insights in the diagnosis of chronic refractory cough. , 2018, Respiratory medicine.
[45] Kathleen M. Tibbetts,et al. Treatment of chronic neurogenic cough with in‐office superior laryngeal nerve block , 2018, The Laryngoscope.
[46] Juliana K Litts,et al. The effect of vocal fold augmentation on cough symptoms in the presence of glottic insufficiency , 2018, The Laryngoscope.
[47] D. Corfield,et al. S35 Randomised control trial quantifying the efficacy of low dose morphine in a responder group of patients with refractory chronic cough , 2017, Thorax.
[48] Surinder S Birring,et al. A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial. , 2017, The Lancet. Respiratory medicine.
[49] M. Farrell,et al. A neuroanatomical framework for the central modulation of respiratory sensory processing and cough by the periaqueductal grey. , 2017, Journal of thoracic disease.
[50] A. Morice,et al. Diagnostic accuracy of fractional exhaled nitric oxide measurement in predicting cough‐variant asthma and eosinophilic bronchitis in adults with chronic cough: A systematic review and meta‐analysis , 2017, The Journal of allergy and clinical immunology.
[51] C. Bucca,et al. Inducible laryngeal obstruction: an official joint European Respiratory Society and European Laryngological Society statement , 2017, European Respiratory Journal.
[52] J. Smith,et al. Effects of a novel sodium channel blocker, GSK2339345, in patients with refractory chronic cough . , 2017, International journal of clinical pharmacology and therapeutics.
[53] M. Farrell,et al. Central mechanisms of airway sensation and cough hypersensitivity. , 2017, Pulmonary pharmacology & therapeutics.
[54] J. Smith,et al. XEN-D0501, a Novel Transient Receptor Potential Vanilloid 1 Antagonist, Does Not Reduce Cough in Patients with Refractory Cough. , 2017, American journal of respiratory and critical care medicine.
[55] J. Smith,et al. Towards understanding and managing chronic cough. , 2016, Clinical medicine.
[56] J. Smith,et al. Chronic Cough Due to Gastroesophageal Reflux in Adults: CHEST Guideline and Expert Panel Report. , 2016, Chest.
[57] V. Backer,et al. Laryngeal Dysfunction: Assessment and Management for the Clinician. , 2016, American journal of respiratory and critical care medicine.
[58] D. Orbelo,et al. Bilateral Thyroarytenoid Botulinum Toxin Type A Injection for the Treatment of Refractory Chronic Cough. , 2016, JAMA otolaryngology-- head & neck surgery.
[59] B. Undem,et al. Vagal Afferent Innervation of the Airways in Health and Disease. , 2016, Physiological reviews.
[60] D. Shaw,et al. The Effects of Azithromycin in Treatment-Resistant Cough: A Randomized, Double-Blind, Placebo-Controlled Trial. , 2016, Chest.
[61] S. Birring,et al. Pregabalin and Speech Pathology Combination Therapy for Refractory Chronic Cough: A Randomized Controlled Trial. , 2016, Chest.
[62] D. Smallwood,et al. Neural correlates of cough hypersensitivity in humans: evidence for central sensitisation and dysfunctional inhibitory control , 2016, Thorax.
[63] A. Negassa,et al. Effect of e-Cigarette Use on Cough Reflex Sensitivity. , 2016, Chest.
[64] S. Birring,et al. Treatment of Unexplained Chronic Cough: CHEST Guideline and Expert Panel Report. , 2016, Chest.
[65] G. Brown,et al. S91 A randomised, double-blind, placebo-controlled crossover study to assess the efficacy of a single dose of 100 mg of VRP700 by inhalation in reducing the frequency and severity of cough in adult patients with Idiopathic Pulmonary Fibrosis , 2015 .
[66] P. Barnes,et al. Cromoglycate: Breathing life into an old asthma drug , 2015 .
[67] J. Smith,et al. Clinical features of the urge-to-cough in patients with chronic cough. , 2015, Respiratory medicine.
[68] G. Bothamley,et al. Cough hypersensitivity syndrome: clinical measurement is the key to progress , 2015, European Respiratory Journal.
[69] S. Birring,et al. Cough hypersensitivity syndrome: clinical measurement is the key to progress , 2015, European Respiratory Journal.
[70] Gary Layton,et al. P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study , 2015, The Lancet.
[71] A. Morice,et al. The global epidemiology of chronic cough in adults: a systematic review and meta-analysis , 2015, European Respiratory Journal.
[72] A. Lindberg,et al. Subjects with COPD and productive cough have an increased risk for exacerbations and death. , 2015, Respiratory medicine.
[73] Huong Q. Nguyen,et al. Anatomy and Neurophysiology of Cough , 2014, Chest.
[74] S. Birring,et al. Expert opinion on the cough hypersensitivity syndrome in respiratory medicine , 2014, European Respiratory Journal.
[75] J. Smith,et al. Transient receptor potential vanilloid 1 (TRPV1) antagonism in patients with refractory chronic cough: a double-blind randomized controlled trial. , 2014, The Journal of allergy and clinical immunology.
[76] Hamilton Morris,et al. From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs. , 2014, Drug testing and analysis.
[77] Wang Juanjuan,et al. Central retinal artery occlusion and cerebral inrfaction following forehead injection with a corticosteroid suspension for vitiligo. , 2014, Indian journal of dermatology, venereology and leprology.
[78] H. Kerstjens,et al. Azithromycin and cough-specific health status in patients with chronic obstructive pulmonary disease and chronic cough: a randomised controlled trial , 2013, Respiratory Research.
[79] J. Smith,et al. Pharmacodynamic modeling of cough responses to capsaicin inhalation calls into question the utility of the C5 end point. , 2013, The Journal of allergy and clinical immunology.
[80] Ashley Woodcock,et al. Predictors of objective cough frequency in chronic obstructive pulmonary disease. , 2013, American journal of respiratory and critical care medicine.
[81] A. Chang,et al. Inhaled corticosteroids for subacute and chronic cough in adults. , 2013, The Cochrane database of systematic reviews.
[82] P. Kahrilas,et al. Response of chronic cough to acid-suppressive therapy in patients with gastroesophageal reflux disease. , 2013, Chest.
[83] S. Birring,et al. Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial , 2012, The Lancet.
[84] J. Smith,et al. Antitussive effects of memantine in guinea pigs. , 2012, Chest.
[85] A. Morice,et al. Chronic cough and esomeprazole: A double‐blind placebo‐controlled parallel study , 2011, Respirology.
[86] A. Chang,et al. Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults. , 2011, The Cochrane database of systematic reviews.
[87] I. Pavord,et al. Long-term low-dose erythromycin in patients with unexplained chronic cough: a double-blind placebo controlled trial , 2010, Thorax.
[88] L. Nelsen,et al. Measuring cough severity: development and pilot testing of a new seven-item cough severity patient-reported outcome measure , 2010, Therapeutic advances in respiratory disease.
[89] P. Raina,et al. The Canadian Longitudinal Study on Aging (CLSA)* , 2009, Canadian Journal on Aging / La Revue canadienne du vieillissement.
[90] P. Davenport,et al. The urge-to-cough and cough motor response modulation by the central effects of nicotine. , 2009, Pulmonary pharmacology & therapeutics.
[91] N. Leidy,et al. Measuring cough severity: Perspectives from the literature and from patients with chronic cough , 2009, Cough.
[92] S. Birring,et al. ERS guidelines on the assessment of cough , 2007, European Respiratory Journal.
[93] A. Morice,et al. Opiate therapy in chronic cough. , 2007, American journal of respiratory and critical care medicine.
[94] A. Jeyakumar,et al. Effectiveness of Amitriptyline Versus Cough Suppressants in the Treatment of Chronic Cough Resulting From Postviral Vagal Neuropathy , 2006, The Laryngoscope.
[95] L. Nield,et al. Chronic Cough , 2006, Clinical pediatrics.
[96] R. Irwin,et al. The New “Face” of CHEST Heralds a New Era , 2006 .
[97] P. Dicpinigaitis. Angiotensin-converting enzyme inhibitor-induced cough: ACCP evidence-based clinical practice guidelines. , 2006, Chest.
[98] L. Boulet,et al. Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. , 2006, Chest.
[99] M. Pratter. Chronic upper airway cough syndrome secondary to rhinosinus diseases (previously referred to as postnasal drip syndrome): ACCP evidence-based clinical practice guidelines. , 2006, Chest.
[100] C. Burt,et al. Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 1999--2000. , 2004, Vital and health statistics. Series 13, Data from the National Health Survey.
[101] Sally J. Singh,et al. Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ) , 2003, Thorax.
[102] K. Fletcher,et al. Evaluation of a cough-specific quality-of-life questionnaire. , 2002, Chest.
[103] T. Fahey,et al. Systematic review of randomised controlled trials of over the counter cough medicines for acute cough in adults , 2002, BMJ : British Medical Journal.
[104] P. Dicpinigaitis,et al. Antitussive Effect of the Leukotriene Receptor Antagonist Zafirlukast in Subjects with Cough-Variant Asthma* , 2002, The Journal of asthma : official journal of the Association for the Care of Asthma.
[105] A. Morice,et al. Gender differences in airway behaviour , 2000, Thorax.
[106] I. Pavord,et al. Eosinophilic bronchitis: an imortant cause of prolonged cough , 2000, Annals of medicine.
[107] F. Hargreave,et al. Nonasthmatic chronic cough: No effect of treatment with an inhaled corticosteroid in patients without sputum eosinophilia. , 1999, Canadian respiratory journal.
[108] G. Pylypchuk. ACE Inhibitor—Versus Angiotensin II Blocker–Induced Cough and Angioedema , 1998, The Annals of pharmacotherapy.
[109] R. Irwin,et al. Impact of chronic cough on quality of life. , 1998, Archives of internal medicine.
[110] M. Adachi,et al. Effect of a leukotriene receptor antagonist on cough receptor sensitivity and allergen-induced cough in a patient with atopic cough variant asthma , 1998 .
[111] R. Irwin,et al. Predictive values of the character, timing, and complications of chronic cough in diagnosing its cause. , 1996, Archives of internal medicine.
[112] R. Irwin,et al. Chronic cough with a history of excessive sputum production. The spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy. , 1995, Chest.
[113] P. Gibson,et al. Chronic cough with eosinophilic bronchitis: examination for variable airflow obstruction and response to corticosteroid , 1995, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[114] M. Hargreaves,et al. Inhaled sodium cromoglycate in angiotensin-converting enzyme inhibitor cough , 1995, The Lancet.
[115] R. Patterson,et al. Outcome of cough variant asthma treated with inhaled steroids. , 1994, Annals of allergy.
[116] K. Chung,et al. Coughing frequency in patients with persistent cough: assessment using a 24 hour ambulatory recorder. , 1994, The European respiratory journal.
[117] W. Hall,et al. Cough and Angioneurotic Edema Associated with Angiotensin-Converting Enzyme Inhibitor Therapy , 1992, Annals of Internal Medicine.
[118] R. Irwin,et al. Chronic cough. The spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy. , 1990, The American review of respiratory disease.
[119] J. Denburg,et al. CHRONIC COUGH: EOSINOPHILIC BRONCHITIS WITHOUT ASTHMA , 1989, The Lancet.
[120] R. Irwin,et al. Chronic persistent cough in the adult: the spectrum and frequency of causes and successful outcome of specific therapy. , 2015, The American review of respiratory disease.